Small molecule profiling to define synergistic <scp>EGFR</scp> inhibitor combinations in head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma

Published:2022-02-27 Issue:5 Volume:44 Page:1192-1205
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Michmerhuizen Nicole L.¹²,Ludwig Megan L.²³,Birkeland Andrew C.²,Nimmagadda Sai²,Zhai Jingyi⁴,Wang Jiayu¹²,Jewell Brittany M.²,Genouw Dylan²,Remer Lindsay²,Kim Daniel²,Foltin Susan K.²,Bhangale Apurva²,Kulkarni Aditi²,Bradford Carol R.²⁵,Swiecicki Paul L.⁶⁵,Carey Thomas E.¹²⁵,Jiang Hui⁴⁵,Brenner J. Chad¹²³⁵^ORCID

Affiliation:

1. Department of Pharmacology University of Michigan Medical School Ann Arbor Michigan USA

2. Department of Otolaryngology—Head and Neck Surgery University of Michigan Medical School Ann Arbor Michigan USA

3. Program in Cellular and Molecular Biology University of Michigan Medical School Ann Arbor Michigan USA

4. Department of Biostatistics University of Michigan School of Public Health Ann Arbor Michigan USA

5. Rogel Cancer Center University of Michigan Medical School Ann Arbor Michigan USA

6. Department of Hematology and Oncology University of Michigan Medical School Ann Arbor Michigan USA

Funder

National Institutes of Health

National Institute of Dental and Craniofacial Research

National Science Foundation

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.27018

Reference60 articles.

1. The molecular biology of head and neck cancer

2. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

3. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

4. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer;Grandis JR;Cancer Res,1993

5. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Wnt/β-catenin signaling pathway for precision therapy in laryngeal squamous cell carcinoma;Oral Oncology Reports;2024-06

2. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma;Archives of Oral Biology;2023-12

3. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment;Cancers;2023-08-24

4. A landscape of response to drug combinations in non-small cell lung cancer;Nature Communications;2023-06-28

5. Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer;The Cancer Journal;2022-09